Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma

Annals of Allergy, Asthma and Immunology

Volumn 86, Issue 3, 2001, Pages 297-303

  Lumry, W ^a   Noveck, R ^b   Weinstein, S ^c   Barnhart, F ^d   Vandermeer, A ^d   Murray, A ^d   Reisner, C ^d  

^a AARA Research Center   (United States)

^b General Clinical Research Center New Orleans   (United States)

^c Allergy and Asthma Specialists Medical Group   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROFLUOROCARBON; NORFLURANE; PLACEBO; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0035078220     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63302-9     Document Type: Article

References (28)

1. Metered-dose pressurized aerosols and the ozone layer
2. The continued need for metered dose inhalers
3. The CFC-ozone issue: Progress on the development of alternatives to CFCs
4. Stratospheric sink for chlorofluoromethanes: Chlorine atom catalysed destruction of ozone
5. CFCs, their replacements, and the ozone layer
6. A United States regulator's perspective on the ongoing chlorofluorocarbon transition
7. Proventil HFA provides bronchodilation comparable to Ventolin over 12 weeks of regular use in asthmatics
8. Proventil HFA and Ventolin have similar safety profiles during regular use
9. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma
10. Efficacy of chlorofluorocarbon-free beclomethasone dipropionate 400 μg day-1 delivered as an extrafine aerosol in adults with moderate asthma
11. Hydrofluoroalkane 134-a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose
12. The Montreal protocol and essential use exemptions
13. Clinical equivalence of a novel nonchlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma
14. Proventil HFA provides protection from exercise-induced bronchoconstriction comparable to Proventil and Ventolin
15. Reference spirometric values using techniques and equipment that meet ATS recommendations
16. Health behaviors and pharmacotherapy
17. Compliance and outcomes in patients with asthma
18. Compliance with treatment regimens in chronic asymptomatic diseases
19. Ventolin HFA administered via the MDI is safe for the long-term treatment of adolescent and adult subjects with asthma
20. Development of a non-CFC inhaler (MDI) system for albuterol sulfate
21. Medical Progress. Asthma
22. Assessment of tachyphylaxis following prolonged therapy of asthma with inhaled albuterol aerosol
23. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutaline
24. Safety of long-term treatment with HFA albuterol
25. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma